The Veterinary Pharmaceuticals Global Market Report 2021-30 by The Business Research Company describes and explains the global veterinary pharmaceuticals market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.
The Veterinary Pharmaceuticals Global Market Opportunities And Strategies Report covers veterinary pharmaceuticals market drivers, veterinary pharmaceuticals market trends, veterinary pharmaceuticals market segments, veterinary pharmaceuticals market growth rate, veterinary pharmaceuticals market major players, and veterinary pharmaceuticals market size.
View Complete Report:
The veterinary pharmaceuticals market report focuses particularly on identifying the trends, opportunities, and strategies that can lead to success. O&S reports are available off the shelf and can be delivered to clients on the day of purchase.
Veterinary Pharmaceuticals Global Market Opportunities And Strategies Report is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
Request For The Sample Now:
Trends in the market include:
Strategic Collaborations And Partnerships To Drive Innovations-
Companies in the veterinary pharmaceuticals industry are increasingly collaborating and partnering with other players to drive product innovations. To succeed in the increasingly competitive veterinary pharmaceuticals market, veterinary medicines companies are entering into new geographies and developing innovative products through sharing skills and expertise with other players. In April 2019, Bayer AG, a German pharmaceutical and life sciences company, collaborated with Adivo GmbH, a biotech company generating therapeutic antibodies for companion animals, to develop therapeutic antibodies for veterinary medicine. Similarly, in June 2018, Merck & Co.’s subsidiary, MSD Animal Health, announced a strategic partnership with Vinovo B.V., a division of Viscon Hatchery Automation, the leading hatchery automation company, to provide a new standard in safe and effective in ovo vaccination to improve bird welfare, reduce vaccine reactions and provide improved protection for the poultry.
Development Of Chewable Tablets-
Chewable tablets are increasingly being used to prevent animals from being affected by ticks, worms, fleas and others. Such tablets are usually soft chew and are available in different flavors such as beef-flavored tablets. Treatments with these tablets are easier to administer than with regular tablets as they can be easily added to regular meals of animals. Many veterinary medicines manufacturers are constantly working towards producing effective and easy-to-give drugs to succeed in the highly consolidated veterinary pharmaceuticals market. For instance, in July 2018, the US FDA approved NexGard (afoxolaner), a chewable tick tablet market by Boehringer Ingelheim, a German pharmaceutical company. The tablet kills certain black-legged ticks, as well as American dog ticks, lone star ticks, and brown dog ticks to prevent flea infections in dogs.
The market is segmented-
By Type Of Pharmaceutical: Veterinary Parasiticides, Veterinary Vaccines, Others – Veterinary Pharmaceuticals, Veterinary Antibiotics
By Animal Type: Livestock, Companion Animal
By Route of Administration: Oral, Others
By End Use Channel: Veterinary Hospitals, Pharmacies And Drug Stores, Veterinary Clinics
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/